ATE79029T1
(de)
*
|
1989-02-11 |
1992-08-15 |
Bayer Ag |
Arzneimittel mit kontrollierter wirkstoffabgabe.
|
US5091185A
(en)
*
|
1990-06-20 |
1992-02-25 |
Monsanto Company |
Coated veterinary implants
|
US5707637A
(en)
*
|
1990-12-14 |
1998-01-13 |
American Cyanamid Company |
Granulated soil insecticidal-nematicidal compositions with reduced mammalian dermal toxicity
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
IT1245889B
(it)
*
|
1991-04-12 |
1994-10-25 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5652196A
(en)
*
|
1991-07-22 |
1997-07-29 |
Oms Investments, Inc. |
Timed release of water-soluble plant nutrients
|
US5335449A
(en)
*
|
1991-08-15 |
1994-08-09 |
Net/Tech International, Inc. |
Delivery system for an agriculturally active chemical
|
US5526607A
(en)
*
|
1991-08-15 |
1996-06-18 |
Net/Tech International |
Water dispersible delivery system for an agriculturally active chemical
|
US5407686A
(en)
*
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
IT1260505B
(it)
*
|
1992-06-01 |
1996-04-09 |
Poli Ind Chimica Spa |
Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
|
FR2692754B1
(fr)
*
|
1992-06-26 |
1995-06-30 |
Ube Industries |
Compositions chimiques pour l'agriculture, en granules a double enrobage.
|
DE69425453T2
(de)
*
|
1993-04-23 |
2001-04-12 |
Novartis Ag |
Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
|
ATE200476T1
(de)
*
|
1993-06-07 |
2001-04-15 |
Oms Investments Inc |
Langzeitabgabe von wasserlöslichen pflanzennährstoffen
|
JP3720386B2
(ja)
*
|
1993-12-27 |
2005-11-24 |
住友製薬株式会社 |
薬物放出制御製剤
|
US5395626A
(en)
*
|
1994-03-23 |
1995-03-07 |
Ortho Pharmaceutical Corporation |
Multilayered controlled release pharmaceutical dosage form
|
SE9402422D0
(sv)
*
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New beads for controlled release and a pharmaceutical preparation containing the same
|
US5698002A
(en)
*
|
1994-11-21 |
1997-12-16 |
Lesco Inc. |
Controlled release fertilizers utilizing an epoxy polymer primer coat and methods of production
|
US5945125A
(en)
*
|
1995-02-28 |
1999-08-31 |
Temple University |
Controlled release tablet
|
US6039975A
(en)
*
|
1995-10-17 |
2000-03-21 |
Hoffman-La Roche Inc. |
Colon targeted delivery system
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
US20060067999A1
(en)
*
|
1996-03-25 |
2006-03-30 |
Wyeth |
Extended release formulation
|
WO1998031221A1
(fr)
*
|
1997-01-20 |
1998-07-23 |
Chisso Corporation |
Granules agrochimiques non enrobes et granules agrochimiques enrobes a temps de liberation controle
|
US5891474A
(en)
|
1997-01-29 |
1999-04-06 |
Poli Industria Chimica, S.P.A. |
Time-specific controlled release dosage formulations and method of preparing same
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US6511477B2
(en)
*
|
1997-03-13 |
2003-01-28 |
Biocardia, Inc. |
Method of drug delivery to interstitial regions of the myocardium
|
KR100522248B1
(ko)
*
|
1997-05-29 |
2006-02-01 |
동아제약주식회사 |
이중제어방출막구조의경구서방성제제및그제조방법
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
ATE238774T1
(de)
*
|
1997-10-09 |
2003-05-15 |
Dexcel Pharma Technologies Ltd |
Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
|
US6607751B1
(en)
*
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
DE69805001T2
(de)
*
|
1997-12-05 |
2002-08-22 |
Alza Corp |
Osmotische darreichungsform mit zwei mantelschichten
|
GR1003326B
(el)
*
|
1998-01-15 |
2000-03-03 |
|
Μεθοδος παραγωγης συστηματων εγκλωβισμου βιολογικα ελεγχομενης αποδοσης
|
DE19820529A1
(de)
*
|
1998-05-08 |
1999-11-11 |
Lohmann Therapie Syst Lts |
Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
WO2001019901A2
(en)
*
|
1999-09-14 |
2001-03-22 |
Smithkline Beecham Corporation |
Process for making aqueous coated beadlets
|
CA2395974A1
(en)
*
|
2000-01-20 |
2001-07-26 |
Suggy S. Chrai |
Multi-step drug dosage forms
|
MXPA02007254A
(es)
*
|
2000-02-04 |
2002-12-09 |
Depomed Inc |
Forma de dosis de cubierta-y-nucleo que se aproxima a liberacion de droga de orden cero.
|
US6761895B2
(en)
*
|
2000-04-17 |
2004-07-13 |
Yamanouchi Pharmaceutical Co., Ltd. |
Drug delivery system for averting pharmacokinetic drug interaction and method thereof
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US6444316B1
(en)
|
2000-05-05 |
2002-09-03 |
Halliburton Energy Services, Inc. |
Encapsulated chemicals for use in controlled time release applications and methods
|
US20030157247A1
(en)
*
|
2000-06-14 |
2003-08-21 |
Yoshiro Chikami |
Method for producing coated bioactive granule
|
JP2004509739A
(ja)
|
2000-09-27 |
2004-04-02 |
ベリオン インコーポレイテッド |
即時水溶解性カプセルおよびその製法
|
US7964216B2
(en)
*
|
2001-01-12 |
2011-06-21 |
Sun Pharma Advanced Research Company Limited |
Spaced drug delivery system
|
CN1499960A
(zh)
|
2001-03-13 |
2004-05-26 |
����˹��ҩ�﹫˾ |
时间治疗剂型
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
RU2324475C2
(ru)
*
|
2001-04-10 |
2008-05-20 |
Сан Фармасьютикал Индастриз Лимитед |
Состав, выделяемый в импульсном режиме в заданное время
|
US6635675B2
(en)
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
CA2470636A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Pharmacia Corporation |
Zero-order sustained released dosage forms and method of making the same
|
AU2002236132A1
(en)
*
|
2002-03-05 |
2003-09-16 |
Ranbaxy Laboratories Limited |
Modified release oral pharmaceutical composition
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7785627B2
(en)
*
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US8084058B2
(en)
*
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US20040086566A1
(en)
*
|
2002-11-04 |
2004-05-06 |
Alpharma, Inc. |
Waxy matrix dosage forms
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
CA2529984C
(en)
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
|
US7220433B2
(en)
*
|
2003-06-27 |
2007-05-22 |
Ethicon, Inc. |
Compositions for parenteral administration and sustained-release of therapeutic agents
|
JP2007505921A
(ja)
|
2003-09-19 |
2007-03-15 |
ペンウェスト ファーマシューティカルズ カンパニー |
遅延放出剤形
|
US8163114B2
(en)
*
|
2004-04-07 |
2012-04-24 |
New Jersey Institute Of Technology |
Netshape manufacturing processes and compositions
|
US20060024361A1
(en)
*
|
2004-07-28 |
2006-02-02 |
Isa Odidi |
Disintegrant assisted controlled release technology
|
US10624858B2
(en)
*
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
US20060246003A1
(en)
*
|
2004-12-27 |
2006-11-02 |
Eisai Co. Ltd. |
Composition containing anti-dementia drug
|
US20090208579A1
(en)
*
|
2004-12-27 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
|
US20060280789A1
(en)
*
|
2004-12-27 |
2006-12-14 |
Eisai Research Institute |
Sustained release formulations
|
EP1830886B1
(en)
*
|
2004-12-27 |
2016-04-13 |
Eisai R&D Management Co., Ltd. |
Method for stabilizing anti-dementia drug
|
US20060204613A1
(en)
*
|
2005-02-18 |
2006-09-14 |
Castro Armando J |
Chewing gum containing flavor delivery systems
|
US20060286200A1
(en)
*
|
2005-04-18 |
2006-12-21 |
Castro Armando J |
Confections containing flavor delivery systems
|
US7943555B2
(en)
*
|
2005-04-19 |
2011-05-17 |
Halliburton Energy Services Inc. |
Wellbore treatment kits for forming a polymeric precipitate to reduce the loss of fluid to a subterranean formation
|
US7905287B2
(en)
|
2005-04-19 |
2011-03-15 |
Halliburton Energy Services Inc. |
Methods of using a polymeric precipitate to reduce the loss of fluid to a subterranean formation
|
DK1889198T3
(da)
|
2005-04-28 |
2015-02-09 |
Proteus Digital Health Inc |
Farma-informatiksystem
|
US8802183B2
(en)
|
2005-04-28 |
2014-08-12 |
Proteus Digital Health, Inc. |
Communication system with enhanced partial power source and method of manufacturing same
|
JP2006327943A
(ja)
*
|
2005-05-23 |
2006-12-07 |
Towa Yakuhin Kk |
経時的溶出遅延を抑制したテイストマスク錠剤
|
US7833945B2
(en)
*
|
2005-07-15 |
2010-11-16 |
Halliburton Energy Services Inc. |
Treatment fluids with improved shale inhibition and methods of use in subterranean operations
|
US8455404B2
(en)
*
|
2005-07-15 |
2013-06-04 |
Halliburton Energy Services, Inc. |
Treatment fluids with improved shale inhibition and methods of use in subterranean operations
|
US20070072775A1
(en)
|
2005-09-29 |
2007-03-29 |
Oms Investments, Inc. |
Granular controlled release agrochemical compositions and process for the preparation thereof
|
WO2007059372A2
(en)
*
|
2005-11-09 |
2007-05-24 |
St. Jude Children's Research Hospital |
Use of chloroquine to treat metabolic syndrome
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US10960077B2
(en)
*
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US8124598B2
(en)
*
|
2006-09-14 |
2012-02-28 |
Sharon Sageman |
7-keto DHEA for psychiatric use
|
ES2400964T3
(es)
|
2007-04-04 |
2013-04-15 |
Sigmoid Pharma Limited |
Composiciones famacéuticas de ciclosporina
|
US20100160274A1
(en)
*
|
2007-09-07 |
2010-06-24 |
Sharon Sageman |
7-KETO DHEA for Psychiatric Use
|
US20110207718A1
(en)
|
2008-08-06 |
2011-08-25 |
Gosforth Centre (Holdings) Pty Ltd. |
Compositions and methods for treating psychiatric disorders
|
CA2750611A1
(en)
*
|
2009-01-22 |
2010-08-12 |
Abbott Healthcare Private Limited |
Chronotherapeutic pharmaceutical composition
|
MY161146A
(en)
*
|
2009-04-28 |
2017-04-14 |
Proteus Digital Health Inc |
Highly-reliable ingestible event markers and methods for using the same
|
JP5845173B2
(ja)
*
|
2009-05-01 |
2016-01-20 |
アデア ファーマスーティカルズ,インコーポレイテッド |
非オピオイドおよびオピオイド鎮痛薬の組み合わせを含む口腔内崩壊錠組成物
|
CN102470106B
(zh)
|
2009-05-18 |
2015-09-23 |
希格默伊德药业有限公司 |
包含油滴的组合物
|
JP2013515741A
(ja)
*
|
2009-12-23 |
2013-05-09 |
サイヴィーダ ユーエス,インコーポレイテッド |
持続放出性送達デバイス
|
CA2795746C
(en)
|
2010-04-07 |
2019-10-01 |
Timothy Robertson |
Miniature ingestible device
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
GB201111712D0
(en)
|
2011-07-08 |
2011-08-24 |
Gosforth Ct Holdings Pty Ltd |
Pharmaceutical compositions
|
WO2015112603A1
(en)
|
2014-01-21 |
2015-07-30 |
Proteus Digital Health, Inc. |
Masticable ingestible product and communication system therefor
|
JP2016508529A
(ja)
|
2013-01-29 |
2016-03-22 |
プロテウス デジタル ヘルス, インコーポレイテッド |
高度に膨張可能なポリマーフィルムおよびこれを含む組成物
|
JP5941240B2
(ja)
|
2013-03-15 |
2016-06-29 |
プロテウス デジタル ヘルス, インコーポレイテッド |
金属検出器装置、システム、および方法
|
AU2014229490A1
(en)
*
|
2013-03-15 |
2015-11-05 |
Adama Makhteshim Ltd |
Artificial environment for efficient uptake of fertilizers and other agrochemicals in soil
|
US9796576B2
(en)
|
2013-08-30 |
2017-10-24 |
Proteus Digital Health, Inc. |
Container with electronically controlled interlock
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
GB201319792D0
(en)
*
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
US20150133516A1
(en)
|
2013-11-13 |
2015-05-14 |
Brian K. Adams |
Methods and Compositions for Treating ADHD
|
ES2858517T3
(es)
|
2014-11-07 |
2021-09-30 |
Sublimity Therapeutics Ltd |
Composiciones que comprenden ciclosporina
|
AU2016288643A1
(en)
|
2015-07-02 |
2018-02-22 |
University Of Louisville Research Foundation, Inc. |
Edible plant-derived microvesicle compositions for delivery of miRNA and methods for treatment of cancer
|
US11051543B2
(en)
|
2015-07-21 |
2021-07-06 |
Otsuka Pharmaceutical Co. Ltd. |
Alginate on adhesive bilayer laminate film
|
SG11201900511VA
(en)
|
2016-07-22 |
2019-02-27 |
Proteus Digital Health Inc |
Electromagnetic sensing and detection of ingestible event markers
|
CA3041041A1
(en)
|
2016-10-26 |
2018-05-03 |
Proteus Digital Health, Inc. |
Methods for manufacturing capsules with ingestible event markers
|